Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BLEXI: A Study of BLEpharospasm Management With daXIbotulinumtoxinA

NCT07489430 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT07489430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07489430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BLEXI: A Study of BLEpharospasm Management With daXIbotulinumtoxinA
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Recruiting
Start date
September 24, 2026
Completion date
December 31, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blepharospasm, blepharospasm of both eyelids, blepharospasm of left eyelid, blepharospasm of right eyelid, blepharospasm, benign essential